By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche today reported that full-year 2009 sales of its molecular diagnostic products rose 2 percent to CHF 1.18 billion ($1.11 billion).

The Swiss drugs, diagnostics, and life science research products firm said that its molecular diagnostics' core blood screening and virology segments "delivered a solid single-digit rise in overall sales."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.